Comparative assessment of beta-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: similarity of inotropic and chronotropic blocking potencies against isoproterenol
- PMID: 6104792
- DOI: 10.1007/BF00569402
Comparative assessment of beta-adrenoceptor blocking agents as simple competitive antagonists in isolated heart muscle: similarity of inotropic and chronotropic blocking potencies against isoproterenol
Abstract
The pattern of antagonism between isoproterenol and various beta-adrenoceptor blocking agents was explored in spontaneously beating right atria and in driven left atrial strips from kittens and guinea pigs. The onset of beta-adrenoceptor blockade is usually very slow in such preparations; incubation periods of up to an hour may be required for equilibrium conditions. The speed of onset of the blocking action is directly related to the concentration of the antagonist, and therefore, for a given degree of blockade, inversely related to its potency. beta-Adrenoceptor blocking agents were found to interact with isoproterenol in a manner consistent with a simple competitive antagonism provided that (1) the antagonist had little intrinsic stimulant action on the preparation under study, (2) the concentrations of antagonist used had no direct depressant action on the preparation, (3) precautions were taken to assure that the pattern of antagonism was not distorted by loss of agonist into tissue sinks, and (4) dose-response curves were normalized for changes in the baseline frequency or force in successive curves. Corrections for desensitization were necessary only in inotropic dose-response curves. Estimates of the equilibrium dissociation constants (KB) derived from the antagonism of the chronotropic and inotropic effects of isoproterenol were determined for fifteen beta-adrenoceptor blocking agents of widely differing potency. In no case was there a substantial difference between the inotropic and chronotropic values. Published estimates of binding constants for beta-blockers determined on cardiac membrane particles are more variable than those determined on intact tissues, and tend to be slightly (adenylyl cyclase measurements) or considerably (radioligand binding studies) lower than the values obtained in intact tissues. These differences raise the possibility that the properties of the beta-adrenoceptor may sometimes be altered during the isolation and partial purification of membrane fragments.
Similar articles
-
Stimulant and depressant effects of beta-adrenoceptor blocking agents on isolated heart muscle. A positive inotropic effect not mediated through andrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 1980 Apr;311(3):205-18. doi: 10.1007/BF00569401. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6104791
-
Vanidipinedilol: a vanilloid-based beta-adrenoceptor blocker displaying calcium entry blocking and vasorelaxant activities.J Cardiovasc Pharmacol. 2000 Jan;35(1):51-63. doi: 10.1097/00005344-200001000-00007. J Cardiovasc Pharmacol. 2000. PMID: 10630733
-
Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.J Pharmacol Exp Ther. 1987 Sep;242(3):1077-85. J Pharmacol Exp Ther. 1987. PMID: 2888870
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
-
The management of acute poisoning due to beta-adrenoceptor antagonists.Med Toxicol Adverse Drug Exp. 1989 Jan-Feb;4(1):32-45. doi: 10.1007/BF03259901. Med Toxicol Adverse Drug Exp. 1989. PMID: 2565523 Review.
Cited by
-
beta-Adrenoceptor blocking agents as partial agonists in isolated heart muscle: dissociation of stimulation and blockade.Naunyn Schmiedebergs Arch Pharmacol. 1980 Apr;311(3):237-48. doi: 10.1007/BF00569403. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6104793
-
Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):27-39. doi: 10.1007/BF00498849. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 2866449
-
Evidence that (+)-bupranolol interacts directly with myocardial beta-adrenoceptors. Control of optical purity with differential thermal analysis.Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(1):1-8. doi: 10.1007/BF00505796. Naunyn Schmiedebergs Arch Pharmacol. 1980. PMID: 6259541
-
An initial characterization of human heart beta-adrenoceptors and their mediation of the positive inotropic effects of catecholamines.Naunyn Schmiedebergs Arch Pharmacol. 1982 Jun;319(3):216-21. doi: 10.1007/BF00495868. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 6287309
-
A novel analysis of concentration-dependence of partial agonism Ring-demethylation of bupranolol results in a high affinity partial agonist (K 105) for myocardial and tracheal beta-adrenoceptors.Naunyn Schmiedebergs Arch Pharmacol. 1982 Aug;320(2):130-44. doi: 10.1007/BF00506313. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 6289139